Weiss Asset Management LP Vertex Pharmaceuticals Inc Transaction History

Weiss Asset Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$181.39 - $202.99 $1.71 Million - $1.91 Million	-9,428 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$187.49 - $221.1 $1.77 Million - $2.08 Million	9,428 New	9,428 $1.9 Million
Q4 2018 Feb 14, 2019	SELL	$151.91 - $192.21 $578,473 - $731,935	-3,808 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$137.28 - $155.55 $294,465 - $333,654	2,145 Added 128.98%	3,808 $571,000
Q3 2017 Nov 14, 2017	BUY	$148.13 - $162.24 $246,340 - $269,805	1,663	1,663 $253,000

1,721

227M

1.21M

1.56M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $127B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Weiss Asset Management LP, based on Form 13F filings with the SEC.

Stay updated on Weiss Asset Management LP with notifications on news.